CAR-T Therapy Survey 2020

Exit Survey
Questions marked with a * are required
100%
1. Which best describes your role with CLL? 
2. What is your age?
3. What is your gender?
3. What is your gender?
4. Please specify your race and ethnicity; select all that apply:
5. What is your or the CLL patient’s status of treatment for CLL?
5. What is your or the CLL patient’s status of treatment for CLL?
6. Regarding the prognostic and predictive factors, I or the patient have: 
Yes
No
Don't know / not sure
Prefer not to say
Deletion 17p
TP 53 Aberration
Deletion11q
IgVH Unmutated (also known as unmutated status)
Complex Karyotype
NOTCH1
Please take a moment to complete the questions below regarding current knowledge and thoughts about CAR-T Therapy, also known as Chimeric Antigen Receptor-T Cell Therapy. 
7. I am confident in my understanding of how CAR-T Therapy works.
7. I am confident in my understanding of how CAR-T Therapy works.
8. I am confident in the safety of CAR-T Therapy.
8. I am confident in the safety of CAR-T Therapy.
9. I am confident in the effectiveness of CAR-T Therapy.
9. I am confident in the effectiveness of CAR-T Therapy.
10. I am confident in my understanding about when someone should consider finding a clinical trial for CAR-T Therapy as a CLL patient. 
10. I am confident in my understanding about when someone should consider finding a clinical trial for CAR-T Therapy as a CLL patient. 
11. I have had CAR-T Therapy.
11. I have had CAR-T Therapy.
12. I am currently considering CAR-T Therapy as my next line of treatment.
12. I am currently considering CAR-T Therapy as my next line of treatment.
13. What would you like to see CLL Society do to help further CAR-T Therapy knowledge or access for CLL patients?
Powered by QuestionPro Privacy & Data Security